TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

LITERATURVERZEICHNIS
cellular distribution of multidrugtransporter proteins in two major causes of medically
intractable epilepsy: focal cortical dysplasia and glioneuronal tumors. Neuroscience 118: 417-
429.
ARONICA, E., GORTER, J.A., RAMKEMA, M., REDEKER, S., OZBAS-GERCERER, F., VAN VLIET,
E.A., SCHEFFER, G.L., SCHEPER, R.J., VAN, D.V., BAAYEN, J.C., TROOST, D., 2004.
Expression and cellular distribution of multidrug resistance-related proteins in the
hippocampus of patients with mesial temporal lobe epilepsy. Epilepsia 45: 441–451.
ARTURSSON, P., 1990. Epithelial transport of drugs in culture. I: a model for studying the passive
diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79: 476-482.
ASCHNER, M., FITSANAKIS, V.A., DOS SANTOS, A.P., OLIVI, L., BRESSLER, J.P., 2006. Bloodbrain
barrier and cell-cell interactions: methods for establishing in vitro models of the bloodbrain
barrier and transport measurements. Methods Mol Biol. 341: 1-15.
BACHMEIER, C.J., TRICKLER, W.J., MILLER, D.W., 2006. Comparison of drug efflux transport
kinetics in various blood–brain barrier models. Drug Metab. Dispos. 34: 998-1003.
BAKOS, É., HOMOLYA, L., 2007. Portrait of multifaceted transporter, the multidrug resistanceassociated
protein 1 (MRP1/ABCC1). Pflugers Arch 453: 621-641.
BALLABH, P., BRAUN, A., NEDERGAARD, M., 2004. The blood-brain barrier: an overview: structure,
regulation, and clinical implications. Neurobiol Dis. 16: 1-13.
BALTES, S., GASTENS, A.M., FEDROWITZ, M., POTSCHKA, H., KAEVER, V., LÖSCHER, W.,
2007a. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and
carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52: 333-346.
BALTES, S., FEDROWITZ, M., LUNA-TORTÓS, C., POTSCHKA, H., LÖSCHER, W., 2007b. Valproic
acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number
of in vitro and in vivo transport assays. J. Pharmacol. Exp. Ther. 320: 331-343.
BANKSTAHL, J.P., HOFFMANN, K., BETHMANN, K., LÖSCHER, W., 2008a. Glutamate is critically
involved in seizure-induced overexpression of P-glycoprotein in the brain. Neuropharmacology
54: 1006-1016.
BANKSTAHL, J.P., LÖSCHER, W., 2008. Resistance to antiepileptic drugs and expression of P-
glycoprotein in two rat models of status epilepticus. Epilepsy Res. 82: 70-85.
BATES, S. F.,CHEN, C., ROBEY, R., KANG, M., FIGG, W.D., FOJO, T., 2002. Reversal of multidrug
resistance: lessons from clinical oncology. Novartis Found Symp. 243: 83-96; discussion 96-
102, 180-05.
BAUER, B., HARTZ, A.M., FRICKER, G., MILLER, D.S., 2004. Pregnane X receptor up-regulation of
P-glycoprotein expression and transport function at the blood-brain barrier. Mol. Pharmacol.
66: 413-419.
BAUER, B., HARTZ, A.M., FRICKER, G., MILLER, D.S., 2005. Modulation of p-glycoprotein transport
function at the blood-brain barrier. Exp. Biol. Med. 230: 118-127.
BAUER, B., HARTZ, A.M., MILLER, D.S., 2007. Tumor Necrosis Factor {alpha} and Endothelin-1
Increase P-Glycoprotein Expression and Transport Activity at the Blood-Brain Barrier. Mol.
Pharmacol. 71: 667-675.
180